HiberCell

Private

Roseville, MinnesotaHealthcare & Life Scienceshttps://hibercell.com/

Last Round

Series B

May 19, 2021

Total Funding Raised

$158.15M

Company Overview

HiberCell is a biotechnology company that develops therapeutic agents targeting adaptive stress pathways and immune modulation to combat cancer treatment resistance, relapse, and metastasis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

cancer relapse and recurrencecancer metastasisdormant disseminated tumor cellsDTCsoncology therapeuticsadaptive stress pathwayscancer drug developmentsmall molecule inhibitorsclinical-stage biotechtumor dormancycancer treatment resistancefirst-in-human compoundoncology pipelinebiopharmaGCN2 activatorPERK inhibitorpharmaceutical partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HiberCell Comps

Public and private peers based on sector, stage, and business model.

HiberCell comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

HiberCell Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	May 19, 2021
Debt	May 19, 2021
Series A	Feb 7, 2019

View all Funding Rounds

HiberCell Investors

Notable investors and investment history

HiberCell investors
Investor	Rounds
Magnetic Ventures	Series B
New York City Economic Development Corporation	Series A
Hercules Capital	Debt, Series B
Hillhouse Investment	Series A
ARCH Venture Partners	Series B, Series A
Magnetic Ventures	Series B
Trinitas Capital Management	Series B

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 19, 2021
$67M round led by Monashee Investment Management and Trinitas Capital Management.

View all signals

HiberCell Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

HiberCell Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HiberCell's valuation, stock price, and market status.

Firmographic Details

HeadquartersRoseville, Minnesota

Employee Range26

Year Founded2018

Last FundingMay 19, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.